ArticleJournal of managed care & specialty pharmacy2026

Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data.

Lindsey Fitzgerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.